| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |